Intuitive Surgical (NASDAQ:ISRG) SVP Sells $316,288.80 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 648 shares of the stock in a transaction on Tuesday, March 3rd. The stock was sold at an average price of $488.10, for a total value of $316,288.80. Following the transaction, the senior vice president owned 5,916 shares of the company’s stock, valued at $2,887,599.60. The trade was a 9.87% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Mark Brosius also recently made the following trade(s):

• On Thursday, March 5th, Mark Brosius sold 648 shares of Intuitive Surgical stock. The shares were sold at an average price of $495.20, for a total transaction of $320,889.60.
• On Wednesday, March 4th, Mark Brosius sold 2,362 shares of Intuitive Surgical stock. The stock was sold at an average price of $498.68, for a total transaction of $1,177,882.16.
• On Monday, December 15th, Mark Brosius sold 464 shares of Intuitive Surgical stock. The shares were sold at an average price of $548.49, for a total transaction of $254,499.36.
• On Friday, December 12th, Mark Brosius sold 4,500 shares of Intuitive Surgical stock. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded down $4.48 during mid-day trading on Thursday, reaching $496.70. The company’s stock had a trading volume of 1,541,063 shares, compared to its average volume of 2,057,887. The firm’s fifty day moving average price is $525.02 and its two-hundred day moving average price is $512.10. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88. The company has a market capitalization of $176.39 billion, a P/E ratio of 62.95, a PEG ratio of 3.83 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.26. The firm had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business’s quarterly revenue was up 18.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.21 earnings per share. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on ISRG shares. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. HSBC boosted their price objective on shares of Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a research note on Monday, January 26th. Piper Sandler reiterated an “overweight” rating and issued a $620.00 target price (up from $610.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. Finally, Evercore decreased their price target on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a report on Friday, January 23rd. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $615.86.

Hedge Funds Weigh In On Intuitive Surgical

Institutional investors have recently made changes to their positions in the stock. Brighton Jones LLC increased its stake in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares during the last quarter. Sivia Capital Partners LLC boosted its holdings in shares of Intuitive Surgical by 3.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after purchasing an additional 34 shares in the last quarter. Schnieders Capital Management LLC. increased its position in shares of Intuitive Surgical by 38.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock valued at $529,000 after purchasing an additional 268 shares during the last quarter. Versor Investments LP bought a new position in shares of Intuitive Surgical during the 2nd quarter valued at about $325,000. Finally, Westside Investment Management Inc. lifted its position in Intuitive Surgical by 1,377.8% in the 2nd quarter. Westside Investment Management Inc. now owns 133 shares of the medical equipment provider’s stock worth $72,000 after buying an additional 124 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.